The US Department of Health and Human Services (HHS) will award $176 million to pharmaceutical and biotechnology company Moderna for the development of an...
Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.
So what exactly did the...